Literature DB >> 14568008

Angiotensin II receptor blockers and angiotensin converting enzyme inhibitors: implication of radical scavenging and transition metal chelation in inhibition of advanced glycation end product formation.

Toshio Miyata1, Charles van Ypersele de Strihou.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14568008     DOI: 10.1016/j.abb.2003.08.010

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


× No keyword cloud information.
  6 in total

1.  Effects of olmesartan on arterial stiffness in rats with chronic renal failure.

Authors:  Yao-Chen Chuang; Ming-Shiou Wu; Yi-Kai Su; Kwang-Ming Fang
Journal:  Cardiovasc Diabetol       Date:  2012-06-13       Impact factor: 9.951

Review 2.  Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome.

Authors:  Suzan Willemsen; Jasper W L Hartog; M Rebecca Heiner-Fokkema; Dirk J van Veldhuisen; Adriaan A Voors
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

Review 3.  Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications.

Authors:  Ryoji Nagai; David B Murray; Thomas O Metz; John W Baynes
Journal:  Diabetes       Date:  2012-03       Impact factor: 9.461

Review 4.  Dietary Metabolites and Chronic Kidney Disease.

Authors:  Sho Hasegawa; Tzu-Ming Jao; Reiko Inagi
Journal:  Nutrients       Date:  2017-04-04       Impact factor: 5.717

5.  Glycyrrhizic Acid Scavenges Reactive Carbonyl Species and Attenuates Glycation-Induced Multiple Protein Modification: An In Vitro and In Silico Study.

Authors:  Sahir Sultan Alvi; Rabia Nabi; Mohd Shahnawaz Khan; Firoz Akhter; Saheem Ahmad; M Salman Khan
Journal:  Oxid Med Cell Longev       Date:  2021-10-11       Impact factor: 6.543

Review 6.  The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes.

Authors:  Robbert Meerwaldt; Thera Links; Clark Zeebregts; Rene Tio; Jan-Luuk Hillebrands; Andries Smit
Journal:  Cardiovasc Diabetol       Date:  2008-10-07       Impact factor: 9.951

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.